Delisting riskPopularity #3,970
GTBP · NASDAQ · Biotechnology

GT Biopharma (GTBP)

Developer of natural-killer-cell engagers for cancer and autoimmune disease.

$6.96
After hours−0.14 (−1.97%)
At close$7.10(−1.11%)